Thomas SA, Patel H
A 41-year-old patient with Metastatic Breast Cancer suffered from
pneumonitis after administration of cyclophosphamide. A CT
angiogram with IV contrast was compatible with bronchopneumonia
and it was treated with broad spectrum antibiotics. Other causes
of pulmonary disease were ruled out concluding patient developed
cyclophosphamide induced pneumonitis. Thus, more attention is
required to the serious and rare side effects of cyclophosphamide
related lung toxicities. In this case report, we will focus on the rare
side effects such as cyclophosphamide-induced pneumonitis (AIP)
occurring in less than 1% of the population.